O
OPKO Health, Inc. (OPK)
NMS – Real vaqt narxi. Valyuta: USD
1.12
-0.05 (-4.27%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
1.12
+0.00 (0.04%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NMS – Real vaqt narxi. Valyuta: USD
1.12
-0.05 (-4.27%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
1.12
+0.00 (0.04%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT
OPKO Health, Inc. AQSh, Irlandiya, Chili, Ispaniya, Isroil, Meksika va xalqaro miqyosda sog'liqni saqlash kompaniyasi sifatida faoliyat yuritadi. Kompaniya ikkita segmentda ishlaydi: Farmatsevtika va Diagnostika. Farmatsevtika segmenti klinik sinovlarning 1-bosqichida bir nechta turdagi qattiq o'smalarga qarshi to'rt spetsifik antitelani ishlab chiqmoqda; klinik sinovlarning 1-bosqichida gematologik o'smalar uchun ikkita antigenga qarshi to'rt spetsifik antitelani ishlab chiqmoqda; va bemorning o'z immunitet tizimini tiklash va qo'llab-quvvatlash uchun uch spetsifik immunitet modulyatorini ishlab chiqmoqda. Ushbu segment, shuningdek, Epstein Barr virusiga qarshi vaksina ishlab chiqish bilan shug'ullanadi; Rayaldee, prohormonni o'z ichiga olgan og'iz orqali yuboriladigan patentlangan uzaytirilgan-reliz mahsuloti; qon glyukozasini tartibga solish va tana vaznini kamaytirish uchun OPK-88006 og'iz va in'ektsion mahsuloti; o'sish gormoni etishmovchiligi bo'lgan bolalarni uzoq muddat davolash uchun ishlab chiqilgan rekombinant inson o'sish gormoni mahsuli NGENLA. Diagnostika segmenti BioReference brendi ostida kasalliklarni aniqlash, tashxislash, baholash, monitoring qilish va davolash, shuningdek, ezoterik testlar, molekulyar diagnostika, anatomik patologiya, genetika, ayollar salomatligi va tuzatuvchi sog'liqni saqlash kabi laboratoriya sinov xizmatlarini taklif etadi; va 4Kscore testi. OPKO Health, Inc. 2006 yilda tashkil etilgan va shtab-kvartirasi Mayami, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Akhtar Ashfaq FACP, FASN, M.D. | Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal |
| Dr. Arie Gutman Ph.D. | President of API |
| Dr. Elias Adam Zerhouni M.D. | President & Vice Chairman |
| Dr. Gary J. Nabel M.D., Ph.D. | Chief Information Officer & Director |
| Dr. Jane H. Hsiao M.B.A., Ph.D. | Vice Chairman & Chief Technical Officer |
| Dr. John R. Mascola M.D. | Chief Scientific Officer of ModeX |
| Dr. Phillip Frost M.D., Ph.D. | Chairman & CEO |
| Mr. Adam E. Logal | Senior VP, CFO, Chief Accounting Officer & Treasurer |
| Mr. Giovanni Abbadessa M.D., Ph.D. | Chief Medical Officer of ModeX |
| Mr. Steven D. Rubin Esq., J.D. | Executive VP of Administration & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2025-10-29 | 10-Q | opk-20250930.htm |
| 2025-09-15 | 8-K | opk-20250915.htm |
| 2025-07-31 | 10-Q | opk-20250630.htm |
| 2025-05-29 | 8-K | opk-20250527.htm |
| 2025-05-01 | 10-Q | opk20250331_10q.htm |
| 2025-04-30 | 8-K | opk20250417_8k.htm |
| 2025-04-23 | 8-K | opk20250417c_8k.htm |
| 2025-04-01 | 8-K | opk20250331_8k.htm |
| 2025-03-28 | 8-K | opk20250327_8k.htm |
| 2025-03-21 | 10-K/A | opk20241231_10ka.htm |